RBC Capital downgrades Randstad (OTC:RANJY) from Outperform to Sector Perform.
Goldman Sachs Maintains Buy on Gossamer Bio, Lowers Price Target to $10
Goldman Sachs analyst Paul Choi maintains Gossamer Bio (NASDAQ:GOSS) with a Buy and lowers the price target from $22 to $10.